ATE455785T1 - Neue pyrazolderivate und diese enthaltende mittel gegen diabetes - Google Patents

Neue pyrazolderivate und diese enthaltende mittel gegen diabetes

Info

Publication number: ATE455785T1
Authority: AT; Austria
Prior art keywords: group; lower alkyl; perfluoro; alkyl group; pyrazole derivatives
Prior art date: 2000-11-02

Application number

AT01978978T

Other languages

English (en)

Inventor

K Ohsumi

T Umemura

H Matsueda

T Hatanaka

A Onuki

K Maezono

Yoko Kageyama

N Kondo

Original Assignee

Ajinomoto Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-02

Filing date

2001-10-31

Publication date

2010-02-15

2001-10-31 Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk

2010-02-15 Application granted granted Critical

2010-02-15 Publication of ATE455785T1 publication Critical patent/ATE455785T1/de

Links

206010012601 diabetes mellitus Diseases 0.000 title abstract 2
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 6
-1 perfluoro Chemical group 0.000 abstract 5
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000002252 acyl group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003217 pyrazoles Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT01978978T 2000-11-02 2001-10-31 Neue pyrazolderivate und diese enthaltende mittel gegen diabetes ATE455785T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000335851		2000-11-02
JP2001131264		2001-04-27
PCT/JP2001/009555 WO2002036602A1 (en)	2000-11-02	2001-10-31	Novel pyrazole derivatives and diabetes remedies containing the same

Publications (1)

Publication Number	Publication Date
ATE455785T1 true ATE455785T1 (de)	2010-02-15

Family

ID=26603344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01978978T ATE455785T1 (de)	2000-11-02	2001-10-31	Neue pyrazolderivate und diese enthaltende mittel gegen diabetes

Country Status (8)

Country	Link
US (6)	US6815428B2 (de)
EP (2)	EP1338603B1 (de)
JP (1)	JP3915116B2 (de)
AT (1)	ATE455785T1 (de)
AU (1)	AU2002210990A1 (de)
DE (1)	DE60141156D1 (de)
ES (1)	ES2337127T3 (de)
WO (1)	WO2002036602A1 (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1020944C (zh)	1990-01-30	1993-05-26	阿图尔-费希尔股份公司费希尔厂	紧固件
KR100591585B1 (ko) *	1999-08-31	2006-06-20	깃세이 야쿠힌 고교 가부시키가이샤	글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체
ES2337127T3 (es) *	2000-11-02	2010-04-21	Ajinomoto Co., Inc.	Nuevos derivados de pirazol y remedios contra la diabetes que los contienen.
JP4591781B2 (ja) *	2000-11-02	2010-12-01	味の素株式会社	新規ピラゾール誘導体及びそれらを含有する糖尿病治療薬
ATE431830T1 (de) *	2000-12-28	2009-06-15	Kissei Pharmaceutical	Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
US7087579B2 (en)	2001-02-26	2006-08-08	Kissei Pharmaceutical Co., Ltd.	Glucopyranosyloxypyrazole derivatives and medicinal use thereof
JP4147111B2 (ja)	2001-02-27	2008-09-10	キッセイ薬品工業株式会社	グルコピラノシルオキシピラゾール誘導体およびその医薬用途
CA2672001A1 (en)	2001-04-27	2002-11-07	Ajinomoto Co., Inc.	N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same
JP4399251B2 (ja)	2001-05-30	2010-01-13	キッセイ薬品工業株式会社	グルコピラノシルオキシピラゾール誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
WO2003020737A1 (en) *	2001-09-05	2003-03-13	Bristol-Myers Squibb Company	O-pyrazole glucoside sglt2 inhibitors and method of use
US7956041B2 (en)	2002-04-26	2011-06-07	Ajinomoto Co., Inc.	Prophylactic and therapeutic agent of diabetes mellitus
CA2484306A1 (en) *	2002-04-26	2003-11-06	Katsumi Maezono	Prophylactic and therapeutic agent of diabetes mellitus
UA79804C2 (en) *	2002-07-03	2007-07-25	Janssen Pharmaceutica Nv	Cck-1 receptor modulators
ZA200501094B (en) *	2002-08-08	2006-10-25	Kissei Pharmaceutical	Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
RU2356906C2 (ru) *	2002-08-08	2009-05-27	Киссеи Фармасьютикал Ко., Лтд.	Производные пиразола, лекарственные композиции, содержащие эти производные, их применение в медицине и промежуточные соединения для их получения
RU2322449C2 (ru)	2002-08-09	2008-04-20	Тайсо Фармасьютикал Ко., Лтд.	ПРОИЗВОДНЫЕ АРИЛ 5-ТИО-β-D-ГЛЮКОПИРАНОЗИДА И ТЕРАПЕВТИЧЕСКИЕ СРЕДСТВА ПРИ ДИАБЕТЕ, СОДЕРЖАЩИЕ ИХ
JP2004137245A (ja) *	2002-08-23	2004-05-13	Kissei Pharmaceut Co Ltd	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
ZA200501549B (en) *	2002-08-23	2006-07-26	Kissei Pharmaceutical	Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof and intermediate for the production thereof
JP4606876B2 (ja) *	2002-08-27	2011-01-05	キッセイ薬品工業株式会社	ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
US7576063B2 (en)	2002-10-04	2009-08-18	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
US20060035844A1 (en) *	2002-12-04	2006-02-16	Fumiaki Ito	Preventive or remedy for diseases caused by hyperglycemia
DE10258008B4 (de) *	2002-12-12	2006-02-02	Sanofi-Aventis Deutschland Gmbh	Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
DE10258007B4 (de) *	2002-12-12	2006-02-09	Sanofi-Aventis Deutschland Gmbh	Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
JP4679155B2 (ja) *	2002-12-25	2011-04-27	キッセイ薬品工業株式会社	含窒素複素環誘導体、それを含有する医薬組成物およびその医薬用途
US7439232B2 (en)	2003-04-01	2008-10-21	Taisho Pharmaceutical Co., Ltd.	Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same
EP1609799A4 (de) *	2003-04-01	2008-10-29	Taisho Pharmaceutical Co Ltd	Heteroaryl-5-thio-beta-d-glucopyranosidderivate und diese enthaltende mittel gegen diabetes
EA200501607A1 (ru) *	2003-04-14	2006-06-30	ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи	Замещённые фенилалкановые кислоты
CA2529878C (en) *	2003-06-20	2012-11-20	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, drug composition containing the same and production intermediate therefor
US8785403B2 (en)	2003-08-01	2014-07-22	Mitsubishi Tanabe Pharma Corporation	Glucopyranoside compound
ES2531660T3 (es)	2003-08-01	2015-03-18	Mitsubishi Tanabe Pharma Corporation	Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio
EP1660509B1 (de) *	2003-08-26	2009-02-04	Boehringer Ingelheim International GmbH	Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US7375090B2 (en)	2003-08-26	2008-05-20	Boehringer Ingelheim International Gmbh	Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
DE102004028241B4 (de) *	2004-06-11	2007-09-13	Sanofi-Aventis Deutschland Gmbh	Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
TW200606129A (en)	2004-07-26	2006-02-16	Chugai Pharmaceutical Co Ltd	Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
EP1805136A1 (de) *	2004-10-28	2007-07-11	The Institutes for Pharmaceutical Discovery, LLC	Substituierte phenylalkansäuren
US7750145B2 (en) *	2004-11-18	2010-07-06	Kissei Pharmaceutical Co., Ltd.	1-substituted-3-β-D-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
WO2006098413A1 (ja) *	2005-03-17	2006-09-21	Kissei Pharmaceutical Co., Ltd.	グルコピラノシルオキシピラゾール誘導体の製造方法
MX2008000011A (es) *	2005-07-22	2008-03-26	Boehringer Ingelheim Int	Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
UY29694A1 (es) *	2005-07-28	2007-02-28	Boehringer Ingelheim Int	Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
UY30082A1 (es)	2006-01-11	2007-08-31	Boehringer Ingelheim Int	Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
US7834050B2 (en)	2006-03-29	2010-11-16	Duke University	Small molecule insulin mimetics absent quinones
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
DE102006028862A1 (de)	2006-06-23	2007-12-27	Merck Patent Gmbh	3-Amino-imidazo[1,2-a]pyridinderivate
US20080020987A1 (en) *	2006-07-20	2008-01-24	Waldemar Pfrengle	Processes for preparing pyrazole-O-glycoside derivatives and novel intermediates of said processes
UY30730A1 (es)	2006-12-04	2008-07-03	Mitsubishi Tanabe Pharma Corp	Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
JP5330260B2 (ja)	2006-12-06	2013-10-30	スミスクラインビーチャムコーポレーション	二環式化合物ならびに抗糖尿病薬としての使用
DE102007008420A1 (de)	2007-02-21	2008-08-28	Merck Patent Gmbh	Benzimidazolderivate
RS56990B1 (sr)	2007-09-10	2018-05-31	Janssen Pharmaceutica Nv	Postupak za dobijanje jedinjenja koja su korisna kao inhibitori sglt
DE102007048716A1 (de)	2007-10-11	2009-04-23	Merck Patent Gmbh	Imidazo[1,2-a]pyrimidinderivate
CL2008003653A1 (es)	2008-01-17	2010-03-05	Mitsubishi Tanabe Pharma Corp	Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
DE102008017590A1 (de)	2008-04-07	2009-10-08	Merck Patent Gmbh	Glucopyranosidderivate
US8791077B2 (en)	2008-05-22	2014-07-29	Astrazeneca Ab	Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same
AU2009286380B2 (en) *	2008-08-28	2011-09-15	Pfizer Inc.	Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
US9056850B2 (en)	2008-10-17	2015-06-16	Janssen Pharmaceutica N.V.	Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en)	2009-07-08	2011-01-13	Yin Liang	Combination therapy for the treatment of diabetes
EP2451797B1 (de)	2009-07-10	2013-04-03	Janssen Pharmaceutica, N.V.	Kristallisationsverfahren für 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorphenyl)-2-thienylmethyl]benzol
EP2298782A1 (de) *	2009-08-26	2011-03-23	Sanofi-Aventis	Verfahren zur Herstellung von Pyrazol-glykosid-Derivate
HUE031375T2 (en)	2009-10-14	2017-07-28	Janssen Pharmaceutica Nv	Process for the preparation of compounds useful as inhibitors of sglt2
RS53827B1 (sr)	2009-11-02	2015-06-30	Pfizer Inc.	Derivati dioksa-biciklo[3.2.1]oktan-2,3,4-triola
AR079438A1 (es)	2009-12-09	2012-01-25	Panacea Biotec Ltd	Derivados de azucar, composiciones farmaceuticas y sus usos
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
SG10201506114UA (en)	2010-05-11	2015-09-29	Janssen Pharmaceutica Nv	Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
EP2697218B1 (de)	2011-04-13	2016-05-25	Janssen Pharmaceutica NV	Verfahren zur herstellung von verbindungen die als sglt2 inhibitoren verwendbar sind
TWI542596B (zh)	2011-05-09	2016-07-21	健生藥品公司	（２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
EP2774619B1 (de)	2013-03-04	2016-05-18	BioActive Food GmbH	Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
EP2944311A1 (de)	2014-05-16	2015-11-18	BioActive Food GmbH	Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen
US20170071970A1 (en)	2015-09-15	2017-03-16	Janssen Pharmaceutica Nv	Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
SG11201907504PA (en)	2017-02-17	2019-09-27	Hyasynth Biologicals Inc	Method and cell line for production of phytocannabinoids and phytocannabinoid analogues in yeast
MA53175A (fr)	2018-07-19	2021-05-26	Astrazeneca Ab	Méthodes de traitement de hfpef au moyen de dapagliflozine et compositions comprenant celle-ci
WO2020039394A1 (en)	2018-08-24	2020-02-27	Novartis Ag	New drug combinations
CN116392472B (zh)	2020-07-27	2025-06-20	阿斯利康(瑞典)有限公司	用达格列净治疗慢性肾脏病的方法
US12409186B2 (en)	2020-07-27	2025-09-09	Astrazeneca Ab	Methods of treating chronic kidney disease with dapagliflozin
EP4315350A1 (de)	2021-04-01	2024-02-07	AstraZeneca UK Limited	Systeme und verfahren zur verwaltung von prädiabetes mit einer pharmazeutischen gliflozin-natrium-glucose-cotransport-2-inhibitorzusammensetzung
US20250108065A1 (en)	2022-01-26	2025-04-03	Astrazeneca Ab	Methods of treating prediabetes or reducing the risk of developing type 2 diabetes with dapagliflozin
TW202525278A (zh)	2023-12-15	2025-07-01	愛爾蘭商阿斯特捷利康愛爾蘭有限公司	治療慢性腎病及高血壓之方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5264451A (en) *	1992-04-07	1993-11-23	American Home Products Corporation	Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
US5274111A (en)	1992-04-07	1993-12-28	American Home Products Corporation	Trifluoromethyl substituted 1H-pyrazoles and derivatives thereof
EP0850946A1 (de)	1996-12-24	1998-07-01	Ciba SC Holding AG	Cyclische Phosphinsäurederivate als Stabilisatoren
PT850948E (pt)	1996-12-26	2002-08-30	Tanabe Seiyaku Co	Derivados propiofenona e processo para a preparacao dos mesmos
KR100591585B1 (ko) *	1999-08-31	2006-06-20	깃세이 야쿠힌 고교 가부시키가이샤	글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체
ES2337127T3 (es) *	2000-11-02	2010-04-21	Ajinomoto Co., Inc.	Nuevos derivados de pirazol y remedios contra la diabetes que los contienen.
ATE431830T1 (de)	2000-12-28	2009-06-15	Kissei Pharmaceutical	Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
US7087579B2 (en)	2001-02-26	2006-08-08	Kissei Pharmaceutical Co., Ltd.	Glucopyranosyloxypyrazole derivatives and medicinal use thereof
CA2672001A1 (en)	2001-04-27	2002-11-07	Ajinomoto Co., Inc.	N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same
JP4115105B2 (ja)	2001-07-02	2008-07-09	協和醗酵工業株式会社	ピラゾール誘導体
US7956041B2 (en) *	2002-04-26	2011-06-07	Ajinomoto Co., Inc.	Prophylactic and therapeutic agent of diabetes mellitus

2001
- 2001-10-31 ES ES01978978T patent/ES2337127T3/es not_active Expired - Lifetime
- 2001-10-31 AT AT01978978T patent/ATE455785T1/de not_active IP Right Cessation
- 2001-10-31 DE DE60141156T patent/DE60141156D1/de not_active Expired - Lifetime
- 2001-10-31 EP EP01978978A patent/EP1338603B1/de not_active Expired - Lifetime
- 2001-10-31 JP JP2002539360A patent/JP3915116B2/ja not_active Expired - Fee Related
- 2001-10-31 AU AU2002210990A patent/AU2002210990A1/en not_active Abandoned
- 2001-10-31 EP EP09013281A patent/EP2163555A1/de not_active Withdrawn
- 2001-10-31 WO PCT/JP2001/009555 patent/WO2002036602A1/ja not_active Ceased
2003
- 2003-05-02 US US10/427,959 patent/US6815428B2/en not_active Expired - Fee Related
2004
- 2004-09-09 US US10/936,535 patent/US7015201B2/en not_active Expired - Fee Related
2005
- 2005-10-24 US US11/255,937 patent/US7247616B2/en not_active Expired - Fee Related
2006
- 2006-12-05 US US11/567,039 patent/US7256209B2/en not_active Expired - Fee Related
2007
- 2007-07-06 US US11/774,102 patent/US7645787B2/en not_active Expired - Fee Related
2009
- 2009-11-19 US US12/621,626 patent/US20100063124A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US6815428B2 (en)	2004-11-09
US7247616B2 (en)	2007-07-24
EP1338603A1 (de)	2003-08-27
US20060058244A1 (en)	2006-03-16
JPWO2002036602A1 (ja)	2004-03-11
ES2337127T3 (es)	2010-04-21
WO2002036602A1 (en)	2002-05-10
US20050043249A1 (en)	2005-02-24
US7015201B2 (en)	2006-03-21
DE60141156D1 (de)	2010-03-11
EP2163555A1 (de)	2010-03-17
US7645787B2 (en)	2010-01-12
EP1338603B1 (de)	2010-01-20
AU2002210990A1 (en)	2002-05-15
US20040006025A1 (en)	2004-01-08
US7256209B2 (en)	2007-08-14
JP3915116B2 (ja)	2007-05-16
US20070270479A1 (en)	2007-11-22
EP1338603A4 (de)	2007-03-28
US20070099979A1 (en)	2007-05-03
US20100063124A1 (en)	2010-03-11

Legal Events

Date	Code	Title	Description
2010-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE455785T1 (de)	2010-02-15	Neue pyrazolderivate und diese enthaltende mittel gegen diabetes
DE69705480D1 (de)	2001-08-09	Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung
AU2284099A (en)	1999-10-18	Poly-aminoacid derivatives and their use in compositions for treating keratinousfibres
ATE327230T1 (de)	2006-06-15	Piperidinverbindungen und diese enthaltenden medikamente
ATE275134T1 (de)	2004-09-15	4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
HUP9802304A2 (hu)	1999-01-28	Piridazin-3-on-származékok, intermedierjeik, alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid készítmények
ES2163478T3 (es)	2002-02-01	Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas.
DE69728544D1 (de)	2004-05-13	Totalsynthese von acylfulvenen mit antitumorwirkung
ATE191473T1 (de)	2000-04-15	2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung
ATE205072T1 (de)	2001-09-15	Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung
ID23053A (id)	2000-01-20	Karboksamida yang digunakan sebagai agonis 5-ht <if>
NO992981D0 (no)	1999-06-17	16-en-vitamin D derivater
DE60207796D1 (de)	2006-01-12	Electrochrome Lösung, enthaltend eine Hydrazonverbindung und mit dieser hergestellte Vorrichtung
DE60016384D1 (de)	2005-01-05	Chondrogonese promotoren und indolin-2-on derivate
BG101442A (en)	1998-03-31	New taxoids, their preparation and pharmaceutical compositions containing them
ATE356112T1 (de)	2007-03-15	Thio-derivate als würzende bestandteile
ATE195517T1 (de)	2000-09-15	Chinolinonderivate und diese enthaltende antiallergische zusammensetzungen
EP1285647A3 (de)	2003-07-02	Kosmetisches Haarpflegemittel enthaltend ein Guanidinderivat und ein N-alpha-Acylarginin
PT1206448E (pt)	2004-08-31	Novos analogos de vitamina d
TR200102205T2 (tr)	2002-01-21	Anti-konvülsan türevlerinin bulimia nevruza tedavisinde kullanılmaları.
ATE265854T1 (de)	2004-05-15	Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
BR0210201A (pt)	2004-06-08	Composição
ATE310111T1 (de)	2005-12-15	Verwendung von organischen karbonaten als lösungsmittel zur reinigung von metalloberflächen
DE60318033D1 (de)	2008-01-24	Biguanid-derivate und deren verwendung als antidiabetika
ES2058783T3 (es)	1994-11-01	Composiciones contra algas que contienen difenileteres e isotiazolonas, procedimientos de control de algas, y composiciones de recubrimiento que contienen las composiciones contra algas.